The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for SD Lee


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.EBI
Universitat De Barcelona
Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.EBI
Gwangju Institute of Science and Technology (Gist)
Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.EBI
Gwangju Institute of Science and Technology (Gist)
Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.EBI
Institute of Science and Technology
Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.EBI
Institute of Science and Technology
5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.EBI
Institute of Science and Technology
Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.EBI
Institute of Science and Technology (Gist)
Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia.EBI
Gwangju Institute of Science and Technology (GIST)
Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.EBI
Seoul National University
Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia.EBI
Gwangju Institute of Science and Technology
Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.EBI
Gwangju Institute of Science and Technology (Gist)
Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.EBI
Gwangju Institute of Science and Technology (Gist)
Development of anti-coxsackievirus agents targeting 3C protease.EBI
Gwangju Institute of School of Life Sciences
Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.EBI
Gwangju Institute of Science and Technology (Gist)
Expression and pharmacological characterization of the human D3 dopamine receptor.BDB
Neuroscience Research Centre